Published in Neurology on May 07, 2008
Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol (2013) 2.30
Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet (2008) 1.71
Neurodegeneration with brain iron accumulation: diagnosis and management. J Mov Disord (2015) 1.52
Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta (2009) 1.45
Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration. Eur J Hum Genet (2011) 1.18
Central nervous system dysfunction in a mouse model of FA2H deficiency. Glia (2011) 1.05
Genetic testing for the spastic paraplegias: drowning by numbers. Neurology (2008) 0.92
Seipin/BSCL2 mutation screening in sporadic adult-onset upper motor neuron syndromes. J Neurol (2009) 0.77
Clinical Spectrum of Hereditary Spastic Paraplegia in Children: A study of 74 cases. Sultan Qaboos Univ Med J (2013) 0.75
A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait. PLoS One (2016) 0.75
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet (2001) 6.96
Diagnostic strategies in CADASIL. Neurology (2002) 3.52
The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet (2001) 2.46
The transcriptome of the arbuscular mycorrhizal fungus Glomus intraradices (DAOM 197198) reveals functional tradeoffs in an obligate symbiont. New Phytol (2011) 2.29
Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat Genet (2000) 2.14
Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res (1999) 1.99
The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr (1988) 1.90
Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development. Am J Hum Genet (2007) 1.88
Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet (1992) 1.72
Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med (1994) 1.71
Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol (1999) 1.65
Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet (1994) 1.58
Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). AIDS Res Hum Retroviruses (1988) 1.58
Homozygous mutation of desmocollin-2 in arrhythmogenic right ventricular cardiomyopathy with mild palmoplantar keratoderma and woolly hair. Cardiology (2008) 1.57
TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology (2011) 1.56
A study of consanguinity in the Sultanate of Oman. Ann Hum Biol (2000) 1.49
Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am J Hum Genet (1994) 1.48
Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia. Clin Genet (2009) 1.46
Complexity of the healthcare crisis in rural America. J Am Osteopath Assoc (1994) 1.39
The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet (1997) 1.37
Intracellular lipid-binding proteins and their genes. Annu Rev Nutr (1997) 1.34
TBX22 mutations are a frequent cause of cleft palate. J Med Genet (2004) 1.30
The natural history of Noonan syndrome: a long-term follow-up study. Arch Dis Child (2006) 1.29
GATA zinc finger interactions modulate DNA binding and transactivation. J Biol Chem (2000) 1.26
Aminoacyltransferase II from rat liver. II. Some physical and chemical properties of the purified enzyme and its adenosine diphosphate ribose derivative. J Biol Chem (1971) 1.25
Aminoacyltransferase II from rat liver. I. Purification and enzymatic properties. J Biol Chem (1971) 1.23
A Noonan-like short stature syndrome with sparse hair. J Med Genet (1986) 1.22
The clinical spectrum of the Fraser syndrome: report of three new cases and review. J Med Genet (1987) 1.20
Abdominal ultrasound in Noonan syndrome: a study of 44 patients. Pediatr Radiol (1993) 1.17
Mannosidosis in two brothers: prolonged survival in the severe phenotype. Clin Genet (1982) 1.16
A computerized approach to dysmorphology. MD Comput (1987) 1.15
A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet (2000) 1.14
Screening for carriers of cystic fibrosis. BMJ (1994) 1.12
Cutis laxa and the Costello syndrome. J Med Genet (1993) 1.11
Psychological profile of children with Noonan syndrome. Dev Med Child Neurol (2005) 1.10
Reduced penetrance in tuberous sclerosis. J Med Genet (1985) 1.07
Pyruvate: ferredoxin oxidoreductase. I. The pyruvate-CO 2 exchange reaction. Arch Biochem Biophys (1971) 1.07
The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. Am J Hum Genet (2001) 1.06
Improved survival after live donor adult liver transplantation (LDALT) using right lobe grafts: program experience and lessons learned. Am J Transplant (2006) 1.06
Recurrent heterozygous missense mutation, p.Gly573Ser, in the TRPV3 gene in an Indian boy with sporadic Olmsted syndrome. Br J Dermatol (2012) 1.05
Pyruvate: ferredoxin oxidoreductase. II. Characteristics of the forward and reverse reactions and properties of the enzyme. Arch Biochem Biophys (1971) 1.02
Ectrodactyly of hands and feet in a child with a complex translocation including 7q21.2. Am J Med Genet (1991) 1.01
Biochemical and crystallographic analyses of a portal mutant of the adipocyte lipid-binding protein. J Biol Chem (1997) 1.01
Neural tube defects and congenital hydrocephalus in the Sultanate of Oman. J Trop Pediatr (1998) 1.00
Major factors determining the frequencies of hemoglobinopathies in Oman. Am J Med Genet (1997) 1.00
Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation (1999) 1.00
Use of next-generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders. J Thromb Haemost (2015) 0.99
Moore-Federman syndrome and acromicric dysplasia: are they the same entity? J Med Genet (1989) 0.99
The clinical features of the Cohen syndrome: further case reports. J Med Genet (1985) 0.97
A mythology of medical education. Lancet (1974) 0.97
Multiple personality disorder. Br J Psychiatry (1989) 0.97
Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. J Biol Chem (2001) 0.97
Non-Mendelian transmission in a human developmental disorder: split hand/split foot. Am J Hum Genet (1994) 0.96
A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members. J Neurol Neurosurg Psychiatry (2001) 0.96
The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome. J Clin Endocrinol Metab (1996) 0.96
Myocardial disarray in Noonan syndrome. Br Heart J (1992) 0.95
A novel locus for hereditary spastic paraplegia with thin corpus callosum and epilepsy. Neurology (2006) 0.94
Analysis of the population structure in Oman. Community Genet (1999) 0.93
SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J Neurol Sci (2003) 0.93
Further delineation of the DOOR syndrome. Clin Dysmorphol (2000) 0.91
Silver syndrome is not linked to any of the previously established autosomal dominant hereditary spastic paraplegia loci. Am J Med Genet (2001) 0.91
Study of hemoglobinopathies in Oman through a national register. Saudi Med J (2000) 0.90
Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. The effect of timing and route of administration. Transplantation (1991) 0.90
Congenital trichomegaly, pigmentary retinal degeneration, and short stature. Am J Ophthalmol (1986) 0.90
A family with craniofrontonasal dysplasia, and fragile site 12q13 segregating independently. Clin Genet (1986) 0.90
Letter: Delayed drug-induced dystonias. Br Med J (1973) 0.89
Congenital and genetic disorders in the Sultanate of Oman. First attempt to assess healthcare needs. J Community Genet (2014) 0.89
Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up. J Clin Endocrinol Metab (2001) 0.89
Novel mutations in the pejvakin gene are associated with autosomal recessive non-syndromic hearing loss in Iranian families. Clin Genet (2007) 0.88
Three new cases of oculodentodigital (ODD) syndrome: development of the facial phenotype. J Med Genet (1985) 0.88
Autosomal dominant palmoplantar hyperkeratosis and sensorineural deafness in three generations. J Med Genet (1992) 0.88
Novel nonsense mutation of the endothelin-B receptor gene in a family with Waardenburg-Hirschsprung disease. Am J Med Genet (1999) 0.88
Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish. Heart (2008) 0.87
Linkage analysis in blepharophimosis-ptosis syndrome confirms localisation to 3q21-24. J Med Genet (1995) 0.87
Floating-Harbor syndrome: description of a further patient, review of the literature, and suggestion of autosomal dominant inheritance. Eur J Pediatr (1995) 0.87
Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene. Hum Mutat (2003) 0.87
Agenesis of the corpus callosum in Turner syndrome with ring X. Dev Med Child Neurol (1997) 0.87
A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia. Neurology (2003) 0.87
Familial microtia with meatal atresia and conductive deafness in five generations. Am J Med Genet (1995) 0.87
Hypertrichosis cubiti (hairy elbows) and short stature: a recognisable association. J Med Genet (1989) 0.86
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation (1996) 0.86
Interaction of aminoacyl transferase II and guanosine triphosphate: inhibition by diphtheria toxin and nicotinamide adenine dinucleotide. Proc Natl Acad Sci U S A (1968) 0.86
Long QT and Harvey-ras. Lancet (1992) 0.86
Translocase activity in the aminoacyl transferase II fraction from rat liver. Biochem Biophys Res Commun (1968) 0.86
Expanding CEP290 mutational spectrum in ciliopathies. Am J Med Genet A (2009) 0.85
Complex allele [-102T>A+S549R(T>G)] is associated with milder forms of cystic fibrosis than allele S549R(T>G) alone. Hum Genet (1999) 0.85
A new locus for autosomal recessive complicated hereditary spastic paraplegia (SPG26) maps to chromosome 12p11.1-12q14. J Med Genet (2005) 0.85